News

AddToAny

Google+ Facebook Twitter Twitter

Effective future antibiotics

Tuberculosis and other life-threatening microbial diseases could be more effectively tackled with future drugs.

Future antibiotics

The claim comes in new research into an old antibiotic by the Francis Crick Institute and the University of Warwick.

Led by Group Leader at the Crick, Luiz Pedro Carvalho, and Professor David Roper at the university, the results have been published in Nature Communications.

Their work reveals a deeper understanding of how the antibiotic D-cycloserineuniquely works at a molecular level. This could lead to more effective future antibiotics, which are desperately needed to fight increasingly drug-resistant and deadly bacteria.

D-cycloserine is an old antibiotic drug that is effective against many microbial diseases, such as tuberculosis, but is often used as a second line treatment, because of some adverse side-effects.

The researchers have discovered that it acts chemically in very different ways on multiple bacterial targets – possibly the only antibiotic in the world to do so.

go.nature.com/2l018I3

Picture credit | iStock

Related Articles

CRISPR-Cas9 gene editing complex, illustration.Image credit - Science-Photo-Library-f0248864

Activating genes using CRISPR technology

There are over 7000 different rare genetic diseases, and often it can be a significant challenge and take a long time to receive a correct diagnosis.

Blue helix human DNA structure-Image credit-shutterstock-1669326868

The search for genes that cause diseases

A new statistical tool developed by researchers at the University of Chicago improves the ability to find genetic variants that cause disease.

pathogenspreadhr-CREDIT-spooky-pooka

Figuring out the threats: Problem-solving with genomics

As the COVID-19 enquiry continues to unpick the tangled threads of the pandemic response, little has been said about one of the most effective weapons against the SARS-Cov-2 virus – pathogen genomics.

breast cancer cells - CREDIT - Science Photo Library-c0559159

Breast cancer cells’ self-sacrifice is potential cause of relapse

For patients with early-stage breast cancer, there is a 7% to 11% chance of relapse within five years after receiving initial treatment.

Top